相似文献
1
Comment on: "Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families.".
Mol Genet Genomic Med. 2020 Jun;8(6):e1243. doi: 10.1002/mgg3.1243. Epub 2020 Apr 6.
2
Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families.
Mol Genet Genomic Med. 2020 Apr;8(4):e1181. doi: 10.1002/mgg3.1181. Epub 2020 Feb 17.
3
Huntington disease and Huntington disease-like in a case series from Brazil.
Clin Genet. 2014 Oct;86(4):373-7. doi: 10.1111/cge.12283. Epub 2013 Oct 17.
4
REVIEW-ARTICLE Intermediate alleles of Huntington's disease HTT gene in different populations worldwide: a systematic review.
Genet Mol Res. 2017 Apr 5;16(2):gmr-16-02-gmr.16029648. doi: 10.4238/gmr16029648.
5
A new mutation for Huntington disease following maternal transmission of an intermediate allele.
Eur J Med Genet. 2015 Jan;58(1):28-30. doi: 10.1016/j.ejmg.2014.11.005. Epub 2014 Nov 20.
6
The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics and to the origin of the mutation.
J Hum Genet. 2006;51(3):189-195. doi: 10.1007/s10038-005-0343-8. Epub 2005 Dec 22.
7
CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease.
J Med Genet. 2013 Oct;50(10):696-703. doi: 10.1136/jmedgenet-2013-101796. Epub 2013 Jul 29.
8
Enhanced Detection and Sizing of the HTT CAG Repeat Expansion in Huntington Disease Using an Improved Triplet-Primed PCR Assay.
Neurodegener Dis. 2016;16(5-6):348-51. doi: 10.1159/000444714. Epub 2016 May 21.
9
Predictive testing for Huntington disease: interpretation and significance of intermediate alleles.
Clin Genet. 2006 Oct;70(4):283-94. doi: 10.1111/j.1399-0004.2006.00668.x.
10
Genetic features of Huntington disease in Cuban population: implications for phenotype, epidemiology and predictive testing.
J Neurol Sci. 2013 Dec 15;335(1-2):101-4. doi: 10.1016/j.jns.2013.08.037. Epub 2013 Sep 3.
本文引用的文献
1
Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families.
Mol Genet Genomic Med. 2020 Apr;8(4):e1181. doi: 10.1002/mgg3.1181. Epub 2020 Feb 17.
2
Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.
J Neurol Sci. 2019 Jul 15;402:57-61. doi: 10.1016/j.jns.2019.05.010. Epub 2019 May 13.
3
Review: Somatic mutations in neurodegeneration.
Neuropathol Appl Neurobiol. 2018 Apr;44(3):267-285. doi: 10.1111/nan.12465. Epub 2018 Feb 28.
4
Clinical manifestations of intermediate allele carriers in Huntington disease.
Neurology. 2016 Aug 9;87(6):571-8. doi: 10.1212/WNL.0000000000002944. Epub 2016 Jul 8.
5
Diagnostic criteria for Huntington's disease based on natural history.
Mov Disord. 2014 Sep 15;29(11):1335-41. doi: 10.1002/mds.26011. Epub 2014 Aug 27.
6
Huntington's disease: how intermediate are intermediate repeat lengths?
Mov Disord. 2012 Dec;27(14):1714-7. doi: 10.1002/mds.25172. Epub 2012 Sep 24.
7
Huntington's disease as caused by 34 CAG repeats.
Mov Disord. 2008 Apr 30;23(6):879-81. doi: 10.1002/mds.21958.
8
Interacting proteins as genetic modifiers of Huntington disease.
Trends Genet. 2007 Nov;23(11):531-3. doi: 10.1016/j.tig.2007.07.007. Epub 2007 Oct 24.
9
Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational study.
J Med Genet. 2007 Mar;44(3):e68. doi: 10.1136/jmg.2006.045120.
10
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3498-503. doi: 10.1073/pnas.0308679101. Epub 2004 Mar 1.
Zotero 插件